A top Wall Street analyst just predicted a 'winter of discontent' for Moderna and shared 3 key reasons the coronavirus vaccine frontrunner's stock is poised to tumble 30%
Moderna CEO Stephane Bancel attends a meeting with President Donald Trump at the White House in March.Moderna, one of the frontrunners in developing a coronavirus vaccine, saw its stock fall by about 10% Tuesday morning, as investors weigh the market for a COVID-19 shot.
While Foroohar expects Moderna's vaccine to succeed in trials, he's not convinced about the commercial opportunity. As a frontrunner in the race for a COVID-19 shot, Moderna has seen its stock surge in 2020, from about $20 to a peak of $95 in July. Foroohar outlined three specific reasons that Moderna could fail to make big profits from its vaccine, even if the shot itself works to prevent the virus.Over the first few months of the pandemic, Moderna was well ahead of other companies in starting human testing and generating early data. But pharmaceutical giants like Pfizerto pivotal data showing whether or not their vaccine candidates work.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Inside the secret club that helps determine which healthcare startups blow up - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Weiterlesen »
Anti-vaxxers could get boost from FDA if coronavirus vaccine authorized prematurelyExperts told Newsweek issuing a vaccine before Phase 3 trials are complete could play into the hands of the movement.
Weiterlesen »
Trump slams Harris for caution on vaccine pushHarris told CNN over the holiday weekend that she would not necessarily trust a vaccine approved by the Trump administration before Election Day.
Weiterlesen »
Japan to spend $6.3 billion from emergency reserve for coronavirus vaccinesThe Japanese government approved on Tuesday spending of 671.4 billion yen ($6.32 billion) from emergency budget reserves to secure coronavirus vaccines, the Ministry of Finance said.
Weiterlesen »
China claims its coronavirus vaccine can protect against all known mutationsBut Professor Ian Jones of the University of Reading told Newsweek the claim 'is a little stretched.'
Weiterlesen »
Pharma CEOs Counter Trump By Promising Safety Over Shortcuts In Coronavirus Vaccine DevelopmentA “historic pledge” is intended to counter President Trump’s insistence that a vaccine could be ready by Election Day.
Weiterlesen »